Yaa‐Hui Dong

1.1k total citations
35 papers, 792 citations indexed

About

Yaa‐Hui Dong is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Yaa‐Hui Dong has authored 35 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Yaa‐Hui Dong's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Asthma and respiratory diseases (4 papers). Yaa‐Hui Dong is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Asthma and respiratory diseases (4 papers). Yaa‐Hui Dong collaborates with scholars based in Taiwan, United States and China. Yaa‐Hui Dong's co-authors include Chia‐Hsuin Chang, Mei‐Shu Lai, Joshua J. Gagne, Lee‐Ming Chuang, Yi‐Cheng Chang, Hsien-Ho Lin, Yun‐Chun Wu, D Chen, Donald Küfe and Yoshinobu Manome and has published in prestigious journals such as Journal of Clinical Investigation, CHEST Journal and BMJ.

In The Last Decade

Yaa‐Hui Dong

31 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaa‐Hui Dong Taiwan 14 247 200 156 121 111 35 792
Clare Ford United Kingdom 17 83 0.3× 222 1.1× 109 0.7× 105 0.9× 53 0.5× 67 885
Allison A. Venner Canada 15 96 0.4× 279 1.4× 133 0.9× 148 1.2× 66 0.6× 40 804
Eunate Arana‐Arri Spain 18 279 1.1× 86 0.4× 195 1.3× 129 1.1× 40 0.4× 69 934
Richard B. Wait United States 19 163 0.7× 156 0.8× 477 3.1× 112 0.9× 102 0.9× 49 1.1k
Lucie Opatrny Canada 14 84 0.3× 111 0.6× 158 1.0× 45 0.4× 190 1.7× 28 938
Tuck Y. Yong Australia 17 120 0.5× 47 0.2× 141 0.9× 171 1.4× 71 0.6× 53 1.0k
Wim Hameeteman Netherlands 16 207 0.8× 170 0.8× 805 5.2× 316 2.6× 25 0.2× 40 1.3k
Jelka Zaletel Slovenia 11 47 0.2× 93 0.5× 116 0.7× 250 2.1× 71 0.6× 32 841
James Welker United States 9 329 1.3× 69 0.3× 171 1.1× 124 1.0× 68 0.6× 14 853
Maxwell A. Asante United Kingdom 10 66 0.3× 62 0.3× 198 1.3× 170 1.4× 93 0.8× 15 549

Countries citing papers authored by Yaa‐Hui Dong

Since Specialization
Citations

This map shows the geographic impact of Yaa‐Hui Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaa‐Hui Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaa‐Hui Dong more than expected).

Fields of papers citing papers by Yaa‐Hui Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaa‐Hui Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaa‐Hui Dong. The network helps show where Yaa‐Hui Dong may publish in the future.

Co-authorship network of co-authors of Yaa‐Hui Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yaa‐Hui Dong. A scholar is included among the top collaborators of Yaa‐Hui Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaa‐Hui Dong. Yaa‐Hui Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Chia‐Chen, et al.. (2024). Effectiveness and Safety of the Coadministration of Rifampin and Warfarin versus Direct Oral Anticoagulants: A Cohort Study. Advances in Pharmacological and Pharmaceutical Sciences. 2024(1). 9694592–9694592.
2.
3.
4.
Dong, Yaa‐Hui, et al.. (2024). Five-year survival prognosis of young, middle-aged, and elderly adult female invasive breast cancer patients by clinical and lifestyle characteristics. Breast Cancer Research and Treatment. 205(3). 619–631. 1 indexed citations
5.
Dong, Yaa‐Hui, Jo‐Hsuan Wu, Chia‐Hsuin Chang, et al.. (2022). Association between glucagon‐like peptide‐1 receptor agonists and biliary‐related diseases in patients with type 2 diabetes: A nationwide cohort study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(6). 483–494. 13 indexed citations
6.
Wang, Hsin, et al.. (2022). Young adult cancer incidence trends in Taiwan and the U.S. from 2002 to 2016. Cancer Epidemiology. 78. 102144–102144. 7 indexed citations
7.
8.
Lai, Chao‐Lun, et al.. (2019). Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design Study. Drugs - Real World Outcomes. 6(3). 93–104. 9 indexed citations
9.
Dong, Yaa‐Hui, et al.. (2018). Use of olmesartan and enteropathy outcomes: a multi‐database study. Alimentary Pharmacology & Therapeutics. 47(6). 792–800. 22 indexed citations
10.
11.
Dong, Yaa‐Hui, Katsiaryna Bykov, Niteesh K. Choudhry, et al.. (2017). Clinical Outcomes of Concomitant Use of Warfarin and Selective Serotonin Reuptake Inhibitors. Journal of Clinical Psychopharmacology. 37(2). 200–209. 10 indexed citations
12.
Chang, Chia‐Hsuin, et al.. (2016). Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study. International Journal of Cardiology. 228. 1007–1014. 9 indexed citations
13.
Bykov, Katsiaryna, Sebastian Schneeweiß, Macarius Donneyong, et al.. (2016). Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors. The American Journal of Cardiology. 119(4). 651–657. 21 indexed citations
14.
Dong, Yaa‐Hui, et al.. (2016). Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study. European Journal of Clinical Pharmacology. 72(10). 1265–1273. 5 indexed citations
15.
Donneyong, Macarius, Katsiaryna Bykov, Pauline Bosco‐Lévy, et al.. (2016). Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study. BMJ. 354. i5014–i5014. 27 indexed citations
16.
Chang, Chia‐Hsuin, et al.. (2015). Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis. BMJ Open. 5(7). e006964–e006964. 101 indexed citations
17.
Dong, Yaa‐Hui, Chia‐Hsuin Chang, Fe‐Lin Lin Wu, et al.. (2014). Use of Inhaled Corticosteroids in Patients With COPD and the Risk of TB and Influenza. CHEST Journal. 145(6). 1286–1297. 61 indexed citations
18.
Lascelles, B. Duncan X., et al.. (2012). Relationship of orthopedic examination, goniometric measurements, and radiographic signs of degenerative joint disease in cats. BMC Veterinary Research. 8(1). 10–10. 71 indexed citations
19.
Dong, Yaa‐Hui, et al.. (2011). Predicting Healthcare Utilization Using a Pharmacy-based Metric With the WHO’s Anatomic Therapeutic Chemical Algorithm. Medical Care. 49(11). 1031–1039. 58 indexed citations
20.
Chen, L, D Chen, Yoshinobu Manome, et al.. (1995). Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter.. Journal of Clinical Investigation. 96(6). 2775–2782. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clare Ford Breakdown of academic impact, for papers by Allison A. Venner Breakdown of academic impact, for papers by Eunate Arana‐Arri Breakdown of academic impact, for papers by Richard B. Wait Breakdown of academic impact, for papers by Lucie Opatrny Breakdown of academic impact, for papers by Tuck Y. Yong Breakdown of academic impact, for papers by Wim Hameeteman Breakdown of academic impact, for papers by Jelka Zaletel Breakdown of academic impact, for papers by James Welker Breakdown of academic impact, for papers by Maxwell A. Asante
Rankless by CCL
2026